Abstract The course of renal involvement and hearing loss is much milder in most female X-linked Alport syndromes than in male patients. We examined the molecular mechanism of development of the disease in a female patient with severe Alport syndrome. The patient showed heavy proteinuria, hematuria, neurosensory hearing loss and primary amenorrhea. Renal biopsy findings of electron microscopy and immunostaining of the α5 chain of type IV collagen indicated a female X-linked Alport syndrome. G-banding chromosomal analysis showed a t(X;1)(q22.3;p36.32) balanced translocation. Analysis of the collagen type IV (COL4A5) gene by genomic DNA sequencing, complementary DNA (cDNA) sequencing and multiplex ligation-dependent probe amplification assay showed no mutations or deletions/duplications of the gene. However, fluorescence in situ hybridization using the probes for exon 1 and exon 51 of the COL4A5 gene showed disruption of one copy of the gene. Replication R-banding chromosomal analysis indicated preferential inactivation of the normal X chromosome. This is the first report of severe Alport syndrome in a female patient carrying a balanced translocation between the chromosome X and 1 producing the disruption of one copy of COL4A5 gene and silencing of the other copy because of preferential inactivation of the normal X chromosome. Chromosomal abnormalities should be considered in female patients with severe forms of Alport syndrome.
Introduction
Alport syndrome is characterized by progressive hematuric nephritis with ultrastructural and immunohistochemical changes of the glomerular basement membrane (GBM), frequently associated with neurosensory hearing loss [1] [2] [3] [4] [5] [6] [7] [8] . Mutations in the collagen type IV (COL4A5) gene are responsible for the more common X-linked dominant form of the disease [online Mendelian Inheritance in Man (OMIM) no. 301050]. Although progression to renal failure and hearing loss is considerably frequent in male X-linked Alport syndrome, the course of renal involvement and hearing loss is much more variable in female patients, remaining mild in the majority of them.
We examined the molecular mechanism of development of the disease in a female patient with severe Alport syndrome, and, we found, for the first time, a balanced translocation between the chromosome X and 1 producing the disruption of one copy of COL4A5 gene and silencing of the other copy because of preferential inactivation of the normal X chromosome.
Methods
All procedures were reviewed and approved by the Institutional Review Board of Kobe University School of Medicine.
Immunohistochemical analysis of kidney biopsy specimens
The immunofluorescence methods used for immunohistochemical analysis have been described previously [9] . Rat monoclonal antibodies that recognize the 2 and 5 chains (H22 and H52; Shigei Medical Research Institute, Okayama, Japan) were used [10] . The expression ratio of type IV collagen α5 chain in the glomerular basement membrane [GBM α5(IV)] was determined with ImageJ 1.42q (National Institutes of Health, Bethesda, MD, USA) on a Macintosh computer (Apple Japan, Tokyo Japan). The whole glomerular tufts and the α5(IV)-positive parts of the glomerular tufts were identified from threshold levels, and the areas of both were measured. The GBM α5(IV) expression ratio was calculated by division of the latter by the former.
Genomic DNA analysis
Genomic DNA was isolated from the patient's peripheral blood leukocytes with the Qiagen kit (Qiagen Inc., Chatsworth, CA, USA), according to the manufacturer's instructions. Specific exons of COL4A5 and exon-intron boundaries were amplified by polymerase chain reaction (PCR), and the PCR-amplified products were purified and directly subjected to sequencing with an automatic DNA sequencer (model ABI Prism 310; Perkin Elmer Applied Biosystems, Foster City, CA, USA).
RNA expression analysis
Total RNA was extracted from blood leukocytes. RNA was isolated with the aid of an Isogen kit (Nippon Gene Co., Toyama, Japan) and was then reverse-transcribed onto complementary DNA (cDNA) by using random hexamers and the Superscript III kit (Invitrogen, Carlsbad, CA, USA). cDNA was amplified by nested PCR using primer pairs for COL4A5 described elsewhere [9, 11] . The PCR-amplified products were purified and directly subjected to sequencing.
Multiplex ligation-dependent probe amplification analysis
To reveal the heterozygous large deletion of the COL4A5 gene, we utilized multiplex ligation-dependent probe amplification (MLPA) analysis using the SALSA P191/192 Alport MLPA assay (MRC-Holland, Amsterdam, The Netherlands).
Fluorescence in situ hybridization analysis Fluorescence in situ hybridization (FISH) was performed according to standard procedures using specific DNA probes for exon 1 and exon 51 of the COL4A5 gene. The probes were synthesized by amplification of human genomic DNA using PCR (Takara LA PCR kit, version 2.1, Takara Bio Inc, Tokyo, Japan). The primers for exon1 of the COL4A5 gene were 5′-CTGCCAGCTTAAGTAGCTAGTGAAACTG-3′ (forward) and 5′-TATCCCACTGACAGTGAATCAGTA CAGG-3′ (reverse), and those for exon 51 of the COL4A5 g e n e w e r e 5 ′ -A C C C C A G G A AT T G A A G T TA CAGTCTGTC-3′ (forward) and 5′-GTGTTGGGTATG CAGTCCACTAACAGAG-3′ (reverse).
Replicating R-banding chromosomal analysis
Peripheral blood lymphocytes were cultured with phytohemagglutinin (PHA) (EY Laboratories, San Mateo, CA, USA), and thymidine (Sigma, St. Louis, MO, USA) was added to synchronize cells at the S/G2 stage. The cells were then rinsed, treated with bromodeoxyuridine (BrdU); Sigma), and incubated in fresh medium for an additional 6 h. Colcemid (Gibco, Grand Island, NY, USA) was added before the final incubation. Chromosome slides were heated, stained with Hoechst 33258 (Sigma), and rinsed in distilled water. The slides were dipped in 2 x standard sodium citrate (SSC), heated, exposed to ultraviolet (UV) light, and stained with 2% Giemsa stain solution (Muto Pure Chemicals Co. Ltd., Tokyo, Japan).
Case report
A female patient suffered from proteinuria and hematuria when she was 2 years old. She underwent renal biopsies at the age of 6 years and 8 years and was diagnosed as having minor glomerular abnormalities. She was diagnosed as having neurosensory hearing loss at the age of 14 years.
She was referred to our hospital at 19 years of age. Her height was 150.3 cm [−1.5 standard deviation (SD)] and her weight was 35.7 kg. Her blood pressure was 120/60 mmHg under treatment with an angiotensin-converting enzyme inhibitor and an angiotensin receptor antagonist. Laboratory investigation showed microscopic hematuria and heavy proteinuria (1.63 g/day) and mild hypoalbuminemia (3.6 g/dl) with normal renal function (creatinine clearance 95.4 ml/min per 1.73 m 2 ). She also had primary amenorrhea, a hypoplastic uterus with no ovaries, and hyper-gonadotrophic hypogonadism. Thus, she was diagnosed as having premature ovarian failure and was treated with estrogen and progesterone.
Results
She underwent renal biopsy again at 19 years of age and was diagnosed as having minor glomerular abnormalities by light microscopy (not shown). However, electron microscopy revealed a widespread basket-weave pattern of GBM (Fig. 1b) . Immunohistochemical staining for α5(IV) collagen revealed mosaic patterns in the GBM (Fig. 1c, d) . We examined ten glomeruli, and the GBM α5(IV) expression ratio was 10-20% in all glomeruli. Therefore, she was diagnosed as having female X-linked Alport syndrome. In addition, the normal X chromosome may have been preferentially inactivated in kidney tissues.
G-banding chromosomal analysis showed a balanced translocation, 46, X, t(X;1)(q22.3;p36.32) (Fig. 2) . Her parents had no chromosomal abnormalities, indicating that her chromosomal abnormality was de novo. COL4A5 gene analysis by genomic DNA sequencing, cDNA sequencing (RNA expression analysis) and multiplex ligationdependent probe amplification assay showed no mutations or deletions/duplications of the gene. However, fluorescence in situ hybridization using the probes for exon 1 and exon 51 of the COL4A5 gene showed disruption of one copy of the gene (Fig. 3a, b) .
To examine the skewed X inactivation, we analyzed the polymorphic regions of the AR gene, the PGK gene and the FMR1 gene, as previously described [12] [13] [14] . However, they were not informative, because the patient showed homozygous status at the three loci. However, replicating R-banding chromosomal analysis revealed that the normal X chromosome was late replicating in all the ten examined cells, indicating that the normal X chromosome was preferentially inactivated, whereas the der(X)t(X;1), bearing the disrupted COL4A5 gene, was active in lymphocytes. (Fig. 3c) .
Discussion
This is the first report of severe Alport syndrome in a female patient carrying a balanced translocation between the chromosome X and autosome. In female Alport . Co-hybridization with the probe for X chromosome-specific alpha satellite DNA (DXZ1: spectrum green) was used to indicate the normal and derivative X chromosome (arrowheads). b FISH analysis with the probe for exon 51 of COL4A5 showed signals (rhodamine) on the normal X chromosome and the derivative chromosome 1, indicating the disruption of one copy of the gene c R-banding chromosomal analysis demonstrated that the normal chromosome X (black arrow) was stained less intensely than the derivative chromosome X (white arrow), indicating that the normal X chromosome was preferentially inactivated syndrome, there is not the genotype-phenotype correlation but the large intrafamilial phenotypic heterogeneity, and risk factors for developing renal failure have been identified: the occurrence and progressive increase in proteinuria, and the development of a hearing defect [15] . Our patient showed heavy proteinuria and neurosensory hearing loss. In addition, her renal biopsy findings revealed a widespread basket-weave pattern of GBM and a low expression rate of the GBM α5(IV). These findings suggested that she was suffering from severe Alport syndrome and had a high risk for the development of renal failure in the future.
In the case of balanced X-autosome translocations arising in female subjects, selective inactivation of the entire X chromosome often occurs. This phenomenon can be the consequence of cell death of the clones inactivating the derivative X-autosome chromosome. In fact, cells carrying derivative X-autosome chromosome would have partial monosomy of the autosome involved and partial disomy of chromosome X, with gene imbalance. The efficacy of this process depends on the position of the X breakpoint and the size of the non-inactivated region and of the autosome genomic segment [16] . In the case of breakage of a gene located on chromosome X, due to translocation of the X-autosome, the predominance of the clones carrying the normal inactive X does not allow the expression of the normal allele of the gene, producing the severe disease phenotype in female X-linked diseases [17] .
Although the detailed breakpoint of the COL4A5 gene was not examined in our study, the disruption of one copy of the gene due to the balanced translocation between chromosomes X and 1 may cause the large structural abnormalities on the encoded protein, α5(IV). In addition, a skewed X-inactivation pattern has been shown to be responsible for the severe phenotypic expression of disease in female carriers of X-linked disease genes [18, 19] . In our study we could not show a skewed expression of the genes (AR, PGK and FMR1) on the X chromosome, because the polymorphic regions of three loci were homozygous in our patient. However, replicating R-banding chromosomal analysis revealed that the normal X chromosome was late replicating in all the cells examined, indicating that the normal X chromosome was preferentially inactivated, whereas the der(X)t(X;1), bearing the disrupted COL4A5 gene, was active. Collectively, the large structural abnormalities of α5(IV) protein and the preferential inactivation of the normal X chromosome might have a pivotal role in the severe phenotype seen in our patient.
Although the replicating R-banding chromosomal analysis showed that the normal X chromosome was inactivated in the lymphocyte examined, 10-20% of glomerular capillaries expressed α5(IV) protein. It is known that not all genes on the X chromosome undergo inactivation. Therefore, it is possible that the results of the replicating Rbanding chromosomal analysis did not necessarily reflect the degree of inactivation of the normal COL4A5 gene. Alternatively, the degree of X inactivation and/or the mRNA splicing of COL4A5 in lymphocytes and glomeruli may have been different in our patient.
Our patient showed primary amenorrhea, which was probably due to X-autosome translocations. A close association between gonadal dysfunction and breakpoints on Xq13-26 (the critical region) has been reported [20] . Recently, it was reported that the critical region was interrupted in Xq21 and was divided into the proximal part (critical region I) and the distal part (critical region II) [21] . Gonadal dysgenesis in female sex chromosome aberrations would primarily be attributable to chromosome pairing failure during meiotic prophase. It is hypothesized that severe pairing failure causes degeneration of nearly all oocytes before puberty, leading to primary amenorrhea [22] . The COL4A5 gene (Xq22.3) is within critical region II. Therefore, the disruption of the COL4A5 gene due to Xautosome translocations in female patients may cause gonadal dysgenesis (primary amenorrhea) by the abovementioned mechanism, as well as severe Alport syndrome.
In other words, we should consider the possibility of Xautosome translocations when female patients with Alport syndrome show gonadal dysfunction.
In conclusion, chromosomal abnormalities should be considered in female patients with severe forms of Alport syndrome, especially in those with gonadal dysfunction including primary amenorrhea.
Besides Alport syndrome, there are several X-linked diseases affecting the kidney, including Dent disease (CLCN5, OCRL), Fabry disease (GLA), dominant hypophosphatemic rickets (PHEX), Lesh-Nyhan syndrome (HPRT), nephrogenic diabetes insipidus (AVPR2), and oral facial digital syndrome 1 (OFD1) [23] . Therefore, we should examine chromosomal abnormalities, including Xautosome translocations, when female patients with these X-linked diseases show severe phenotype and other abnormalities, including gonadal dysgenesis.
